Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Androgen Replacement in Hypogonadal Males With CAD Post-PCI
NCT00413244Phase 3Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jan 2007
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of AndroForte in coronary artery disease (CAD), sponsored by Icahn School of Medicine at Mount Sinai. Started Jan 2007; status: completed.
02
Drugs
AndroForte
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00413244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00413244.